Indeed, the comments from readers on WSJ I must comment shows a very shallow understanding of emerging markets (of course ignore the snarly ones). I think this product can be successful if the pricing/marketing model is tweaked. I am not sure if users will be willing to pay for scratch cards to verify a drug that can be fake or real? What if it is fake? Double cost? I think there might be room for collaboration here..
Contacts of the day:
Frontline US based VC Firm focused on Africa's frontier markets led by the affable Marsha Wullf. Am encouraged by their activities in Kenya, Nigeria and South Africa. Healthcare & Energy are core competencies.
This organization provides grants, supports innovators and organize conference. Open 2010 in San Francisco is upcoming. Register today!
Want Money to fund your ideas??
Well, try these guys out..their angel list is now tops http://techcrunch.com/2010/02/03/startuplist-angel-investors/